$1.42
▲ +1.4% Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference
Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
Overview
52-week range
$1.25
$28
1% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
-6.7%
0% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-2.94 | — | — | — | — | financials |
| Thu May 14, 2026 | Mar/2026 | $-0.43 | — | — | -138.9% | -5.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-2.21 | — | — | — | — | financials |
| Fri Aug 8, 2025 | Jun/2025 | $-1.99 | — | — | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.18 | — | — | — | -8.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-7.75 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-16.75 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-2.03 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.41 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-14.24 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.75 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | $-4M | — | $-5M | $-6M | $-5M | — | $-5M |
| Net income | $-4M | $-4M | — | $-5M | $-6M | $-5M | — | $-5M |
| EPS (diluted) | $-2.94 | $-0.43 | — | $-2.21 | $-31.75 | $-2.21 | — | $-7.75 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $7M | $6M | $10M | $5M | $11M | — | $2M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $5M | $7M | $6M | $11M | $6M | $11M | $10M | $2M |
| Total assets | $7M | $10M | $9M | $14M | $9M | $15M | $14M | $7M |
| Long-term debt | $600,000 | $600,000 | $600,000 | $600,000 | $600,000 | $600,000 | $600,000 | $2M |
| Total liabilities | $4M | $5M | $5M | $7M | $7M | $8M | $12M | $16M |
| Total equity | $3M | $5M | $4M | $7M | $2M | $7M | $2M | $-10M |
Implied volatility — last 90 days
No IV snapshots yet for CLDI.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.